Lung cancer screening trail
MD Anderson Cancer Center is starting a clinical trial with a goal of improving lung cancer screening so that more lung cancer patients are diagnosed in the early stages of the disease, when it’s still treatable.
Locating lung cancer faster to boost survival rates
November 07, 2014
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on November 07, 2014
During MD Anderson’s recent Moon Shots Program event, a new clinical trial aimed at detecting lung cancer at an earlier stage was highlighted.
The trial, which will involve a newly-developed blood test paired with CT Scans, is being led my MD Anderson researcher Sam Hanash, M.D., Ph.D., professor of Clinical Cancer Prevention-Research.
While several details of the study have yet to be announced, this video was played at the moon shots event and highlights the goals and hopes for the study.